NCT02488798

Brief Summary

100 patients with postmenopausal bleeding were assessed with 2D vaginal ultrasound and 3D power Doppler ultrasound using the international endometrial tumor analysis group and office hysteroscopy with taking samples for histopathological analysis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
Last Updated

July 2, 2015

Status Verified

June 1, 2015

Enrollment Period

1.5 years

First QC Date

June 30, 2015

Last Update Submit

June 30, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy of 3D power Doppler ultrasound with the IETA group criteria in diagnosing the cause of postmenopausal bleeding

    Efficacy of 3D power Doppler ultrasound with the IETA group criteria in diagnosing the cause of postmenopausal bleeding

    1 week

Study Arms (1)

postmenopausal bleeding group

100 women with postmenopausal bleeding undergoing 2D greyscale vaginal ultrasound and 3D Endometrial power Doppler and the features were classified using six different vascular patterns described by IETA group including the following patterns; single dominant vessel without branching, with branching, multiple vessels with focal origin, with multifocal origin at the myometrium-endometrium junction, scattered vessels or circular flow (Kucur et al., 2013 ). All patients then had Office hysteroscopy carried out in the outpatient clinic using vaginoscopic approach (Cooper et al., 2010). With endometrial samples from lesions or from the cavity for histopathological analysis.

Procedure: 2D grey scale vaginal ultrasoundProcedure: 3D power Doppler vaginal ultrasoundProcedure: Office hysteroscopy

Interventions

To assess the endometrial thickness and echogenicity (whether the endometrium is uniform or non-uniform).

postmenopausal bleeding group

To assess the endometrium using the IETA group criteria.

postmenopausal bleeding group

using the vaginoscopic approach to assess the uterine cavity and take sample.

postmenopausal bleeding group

Eligibility Criteria

Age47 Years - 64 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with postmenopausal bleeding

You may qualify if:

  • patients complaining of postmenopausal bleeding. Postmenopausal bleeding was defined as vaginal bleeding that occurred after at least 12 months of amenorrhea.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Sample from the uterine endometrium for histopathological analysis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

June 30, 2015

First Posted

July 2, 2015

Study Start

June 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

July 2, 2015

Record last verified: 2015-06